About us

🧬 About Care ON Time MTFS

Care ON Time MTFS is a specialized provider of advanced medical services in the UAE, proudly established under the Dubai government in 2019, with registration under trade license No. 858940.
Initially focused on general medical services, we made a strategic shift in January 2022 toward delivering cutting-edge molecular profiling solutions for cancer patients. This transformation began with our collaboration with OncoDNA, a leading Belgian company renowned for its expertise in molecular oncology. As their local partner in the UAE, we are committed to introducing innovative, clinically actionable genomic solutions tailored to the needs of physicians and patients across the country.
In May 2023, we expanded our portfolio through a regional agreement with Valentis (Turkey) and Veracyte (France), enabling the introduction of Prosigna®—a globally validated breast cancer prognostic test—into the UAE market. This milestone solidified our role as a key player in personalized oncology diagnostics.
Continuing our growth, in October 2024, we proudly added ThyroSeq® Genomic Classifier to our offerings. ThyroSeq brings advanced molecular testing for indeterminate thyroid nodules (Bethesda III/IV), empowering clinicians in the UAE with accurate, personalized insights for confident thyroid cancer diagnosis and management.

🎯 Our Mission

To advance patient care by enabling access to world-class diagnostic technologies that support early detection, precise treatment selection, and continuous disease monitoring — all while keeping the needs of local clinicians and patients at the center.

👨‍⚕️ Led by Expertise

Care ON Time MTFS is led by Hesham Attia, a seasoned professional with over a decade of experience in oncology diagnostics across the Gulf region. He is recognized for cultivating strategic partnerships, earning the trust of key opinion leaders, and successfully introducing pioneering tests to the UAE’s most prominent hospitals and cancer centers.

🤝 Our Key Partners